The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.360. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R37CA258829-04
Mechanisms of liver metastasis and associated resistance to immunotherapy
National Institutes of Health
Grant: 3P30CA013696-21S1
CANCER CENTER CORE SUPPORT GRANT
National Institutes of Health
Grant: 1S10OD020056-01
BD Biosciences Influx
National Institutes of Health
Grant: 7K08CA222663-04
Dissecting mechanisms of immunotherapy resistance in melanoma patients
National Institutes of Health
Grant: 2T32GM007367-24
MEDICAL SCIENTIST TRAINING PROGRAM
National Institutes of Health
Grant: 5R01CA238039-05
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
Fields of Study
Keywords
Sustainable Development Goals